{"log_id": 3430240912918217145, "direction": 0, "words_result_num": 48, "words_result": [{"probability": {"variance": 0.035155, "average": 0.825211, "min": 0.479531}, "location": {"width": 703, "top": 61, "height": 36, "left": 141}, "words": "会曲林20Umg与格列本或地高平之间无相互作"}, {"probability": {"variance": 0, "average": 0.705029, "min": 0.705029}, "location": {"width": 63, "top": 36, "height": 70, "left": 1544}, "words": "堂"}, {"probability": {"variance": 0.015287, "average": 0.907066, "min": 0.559214}, "location": {"width": 1055, "top": 102, "height": 43, "left": 205}, "words": "屯克治疗(ECT):尚无考舍曲林与电体克冶疗合用优点或危险方面的临庆试验"}, {"probability": {"variance": 0.015945, "average": 0.946122, "min": 0.425154}, "location": {"width": 1269, "top": 143, "height": 50, "left": 198}, "words": "细胞色素P450(YP)2D6代谢的药物:抗排郁药物对药物代谢司动酶CYP2D6的抑制作用程度是"}, {"probability": {"variance": 0.01811, "average": 0.933673, "min": 0.462609}, "location": {"width": 1329, "top": 185, "height": 50, "left": 137}, "words": "不尽相同的.其临床意义需取决于抑制作用的程度及合用药物的治疗指数,治疗指数较交的CYP2D6底物"}, {"probability": {"variance": 0.017888, "average": 0.902017, "min": 0.513173}, "location": {"width": 1311, "top": 226, "height": 52, "left": 132}, "words": "包括加普罗咱酮( propane. onc).氟卡尼( flecainide)在内的三环类抗抑郁药物和1C类抗心律先常药物"}, {"probability": {"variance": 0.005949, "average": 0.96714, "min": 0.604984}, "location": {"width": 934, "top": 271, "height": 43, "left": 134}, "words": "已有的药互作用研究表明,每日50mg舍由林长期给药可使地西帕明"}, {"probability": {"variance": 0.00336, "average": 0.948516, "min": 0.804778}, "location": {"width": 262, "top": 285, "height": 31, "left": 1201}, "words": ",CYP2D6同功酶活"}, {"probability": {"variance": 0.00681, "average": 0.966936, "min": 0.613993}, "location": {"width": 708, "top": 317, "height": 36, "left": 134}, "words": "性的标志物)稳态的血药浓度轻度培加(平均30-40%"}, {"probability": {"variance": 0.014692, "average": 0.952259, "min": 0.401639}, "location": {"width": 1048, "top": 360, "height": 41, "left": 196}, "words": "其他细胞色素(CYP)酶代谢的药物(CYP3A34,CYP2C9,CYP2C19,CYP1A2):"}, {"probability": {"variance": 0.005617, "average": 0.967564, "min": 0.660277}, "location": {"width": 1265, "top": 399, "height": 52, "left": 198}, "words": "CYP3A3/4:体内药物相互作用试验表明长期服用舍曲林200mg日不会对CYP3A34介导的内生皮"}, {"probability": {"variance": 0.009667, "average": 0.966415, "min": 0.435649}, "location": {"width": 1329, "top": 443, "height": 50, "left": 130}, "words": "质醇的羟化或卡马西平及特非那定的代谢产生抑制作用另外,每日50mg舍曲林长期给药不会对CYP"}, {"probability": {"variance": 0.016722, "average": 0.960682, "min": 0.397537}, "location": {"width": 1105, "top": 484, "height": 47, "left": 130}, "words": "3A34介导的阿普唑伦药物代谢产生抑制作用。这说明林不是CYP3A34的抑制剂"}, {"probability": {"variance": 0.008098, "average": 0.95439, "min": 0.573128}, "location": {"width": 1265, "top": 525, "height": 52, "left": 196}, "words": "CYP2C9:长期服用舍曲林200mg/日对甲苯磺丁、苯妥英和华法林的血药浓度没有明显影响。这"}, {"probability": {"variance": 0.007999, "average": 0.961711, "min": 0.589458}, "location": {"width": 561, "top": 571, "height": 38, "left": 130}, "words": "说明舍曲林不是CYP2C9的临床相关抑制剂"}, {"probability": {"variance": 0.014317, "average": 0.94563, "min": 0.36812}, "location": {"width": 1263, "top": 609, "height": 50, "left": 196}, "words": "CYP2C19:长期服用舍曲林200mg/E对地西洋药浓度无明显影响,说明舍曲林也非CYP2C19的"}, {"probability": {"variance": 0.001215, "average": 0.95911, "min": 0.914716}, "location": {"width": 86, "top": 657, "height": 31, "left": 130}, "words": "抑制剂"}, {"probability": {"variance": 0.005113, "average": 0.95943, "min": 0.739718}, "location": {"width": 822, "top": 698, "height": 38, "left": 194}, "words": "CYP1A2:体外试验研究表明舍曲林对CYP1A2无明显抑制咋用"}, {"probability": {"variance": 0.021322, "average": 0.930879, "min": 0.36732}, "location": {"width": 1276, "top": 737, "height": 52, "left": 182}, "words": "其它-色肢能药物:曲林与可增强5羟色胺神经传导作用的药物如色酸或芬氟拉明合用时应慎"}, {"probability": {"variance": 0.000187, "average": 0.994243, "min": 0.939302}, "location": {"width": 523, "top": 783, "height": 38, "left": 125}, "words": "重考虑,避免出现可能的药效学相互作用"}, {"probability": {"variance": 2e-05, "average": 0.996856, "min": 0.987013}, "location": {"width": 157, "top": 829, "height": 34, "left": 134}, "words": "【药物过量】"}, {"probability": {"variance": 0.016228, "average": 0.938055, "min": 0.475193}, "location": {"width": 1263, "top": 865, "height": 50, "left": 180}, "words": "有证据表明,舍由林在过量服用时仍有很大的安全范围。曾有舍曲林单独过量服用高达13.5克的报道"}, {"probability": {"variance": 0.008021, "average": 0.973097, "min": 0.396983}, "location": {"width": 1329, "top": 911, "height": 45, "left": 123}, "words": "曾有过量用舍曲林导致死亡的报道,但大多出现于与其它药物和或酒精联合应用的情况下。因此,应对"}, {"probability": {"variance": 3.9e-05, "average": 0.992688, "min": 0.98374}, "location": {"width": 342, "top": 954, "height": 34, "left": 125}, "words": "任何用药过量给予积极治疗"}, {"probability": {"variance": 0.020198, "average": 0.943901, "min": 0.363146}, "location": {"width": 1276, "top": 998, "height": 38, "left": 178}, "words": "药物过量症状包括有因5羟色胺引起的不臭反应如睡、胃肠不适如恶心和呕叶)、心动过速、震"}, {"probability": {"variance": 0.011221, "average": 0.952035, "min": 0.571867}, "location": {"width": 1320, "top": 1039, "height": 41, "left": 121}, "words": "题,激动和头晕。罕有香迷报道。舍曲林没有特效的解毒剂。开放并保持气道通畅确保充分的供氧及换气"}, {"probability": {"variance": 0.005698, "average": 0.980795, "min": 0.493974}, "location": {"width": 1333, "top": 1080, "height": 41, "left": 121}, "words": "可与导泻剂合用活性炭:可能与催吐或洗胃同样甚或更为有效。在对症治疗及支持疗法同时,建议进行心"}, {"probability": {"variance": 0.013986, "average": 0.960782, "min": 0.404578}, "location": {"width": 1317, "top": 1123, "height": 43, "left": 121}, "words": "脏及生命征监测。由于舍由林有较大分布容积,强迫利尿,透析,血液灌注及换血疗法没有明显意义"}, {"probability": {"variance": 0.000667, "average": 0.984885, "min": 0.928113}, "location": {"width": 150, "top": 1169, "height": 34, "left": 127}, "words": "【药理毒理】"}, {"probability": {"variance": 0, "average": 0.999238, "min": 0.998138}, "location": {"width": 114, "top": 1212, "height": 31, "left": 178}, "words": "药理作用"}, {"probability": {"variance": 0.005083, "average": 0.967453, "min": 0.620736}, "location": {"width": 1276, "top": 1249, "height": 47, "left": 175}, "words": "盐酸舍曲林是一种选择性的5-轻色重摄取抑制剂,其作用机制与其对中枢神经元5羟色胺重摄取的"}, {"probability": {"variance": 0.01691, "average": 0.940611, "min": 0.389949}, "location": {"width": 1331, "top": 1295, "height": 41, "left": 118}, "words": "抑制有关,在临床剂量下,曲林阻断人血小板对5-羟色的摄取。研究提示舍曲林是一种强效和选择性"}, {"probability": {"variance": 0.006029, "average": 0.962725, "min": 0.620139}, "location": {"width": 1333, "top": 1336, "height": 45, "left": 116}, "words": "的神经元5羟色胺重摄取抑制剂,对去甲肾上腺素和多巴腔仅有微弱影响。体少研究显示,舍白林对肾上"}, {"probability": {"variance": 0.046207, "average": 0.776615, "min": 0.352219}, "location": {"width": 187, "top": 1379, "height": 34, "left": 116}, "words": "索能受体〔a"}, {"probability": {"variance": 0.023211, "average": 0.917145, "min": 0.394883}, "location": {"width": 1002, "top": 1381, "height": 36, "left": 408}, "words": "β)、胆碱能受体,GABA受体、多巴胺能受体、组受体,5-羟色胺能受体(5HT"}, {"probability": {"variance": 0.005894, "average": 0.963283, "min": 0.560251}, "location": {"width": 1324, "top": 1422, "height": 43, "left": 125}, "words": "HT1B,5HT2)或苯二氮卓受体没有明显的亲和力。对上述受体的洁抗作用校认为与其他精神疾病用药的"}, {"probability": {"variance": 0.014028, "average": 0.954721, "min": 0.472163}, "location": {"width": 1333, "top": 1464, "height": 41, "left": 116}, "words": "镇静作用、抗脂碱作用和心肥毒性相关。动物长期给予舍曲林可使髓中去甲肾上腺素受体下调,这与临床"}, {"probability": {"variance": 0.001314, "average": 0.98528, "min": 0.820034}, "location": {"width": 874, "top": 1507, "height": 36, "left": 118}, "words": "上其它抗抑郁症药物的作用一致。舍曲林对单胺氧化酶没有抑制作用"}, {"probability": {"variance": 0.00292, "average": 0.920302, "min": 0.848971}, "location": {"width": 116, "top": 1560, "height": 31, "left": 173}, "words": "毒理研究"}, {"probability": {"variance": 0.009804, "average": 0.962619, "min": 0.548389}, "location": {"width": 1281, "top": 1605, "height": 47, "left": 169}, "words": "退传毒性:细菌突变试验、小鼠淋巴瘤突变试验、在体小鼠骨髓和体外人淋巴细胞遗传学试验结果表"}, {"probability": {"variance": 0.011106, "average": 0.962178, "min": 0.490789}, "location": {"width": 726, "top": 1653, "height": 36, "left": 116}, "words": "明,在有或无代谢激活存在,舍由林均未出现遗传毒性"}, {"probability": {"variance": 0.020144, "average": 0.928558, "min": 0.369405}, "location": {"width": 1276, "top": 1703, "height": 43, "left": 169}, "words": "生殖毒性:给药剂量为8mg/kg(以mg/m2汁,为人最大推荐剂量MRHD的4倍时,两个大鼠试验"}, {"probability": {"variance": 0.010704, "average": 0.958267, "min": 0.45922}, "location": {"width": 1336, "top": 1747, "height": 38, "left": 111}, "words": "之一观察到动物生育力降低。在大鼠和家兔上进行了剂量分别达8Cmg/ keay和40mg/kg/day的生殖毒性"}, {"probability": {"variance": 0.002114, "average": 0.975905, "min": 0.794252}, "location": {"width": 1333, "top": 1788, "height": 41, "left": 109}, "words": "研究(以mg/m2计约相当于人最大推荐剂量的4倍),在各试验剂量下均未发现致畸作用。怀孕大鼠和家"}, {"probability": {"variance": 0.012007, "average": 0.931335, "min": 0.439115}, "location": {"width": 1333, "top": 1829, "height": 41, "left": 109}, "words": "兔在器言形成期给予家盘含曲林(剂量分别为10mg/kg和40mgkg,以mg/m2计约相当于MRHD的0.5倍"}, {"probability": {"variance": 0.012944, "average": 0.947197, "min": 0.547834}, "location": {"width": 1331, "top": 1872, "height": 41, "left": 111}, "words": "和4倍〕时观察到胎仔骨化延迟。雌性大鼠妊娠后期及哺乳期给予曲林,剂量20mgkg下死产幼鼠及出"}, {"probability": {"variance": 0.01068, "average": 0.949883, "min": 0.575926}, "location": {"width": 1331, "top": 1911, "height": 50, "left": 109}, "words": "生后前4天幼鼠死亡数量增加,出生后前4天幼鼠的体重亦降低,时大鼠幼鼠无彩响剂量为10mgkg。幼"}, {"probability": {"variance": 0.00156, "average": 0.979569, "min": 0.829245}, "location": {"width": 1023, "top": 1955, "height": 41, "left": 107}, "words": "鼠存活率的降低是由舍由林在子宫的暴露所致。但这些作用的临床义尚不清楚"}], "language": 3}